HRP20090104T3 - Kruti farmaceutski pripravak koji sadržava donepezil hidroklorid - Google Patents
Kruti farmaceutski pripravak koji sadržava donepezil hidrokloridInfo
- Publication number
- HRP20090104T3 HRP20090104T3 HR20090104T HRP20090104T HRP20090104T3 HR P20090104 T3 HRP20090104 T3 HR P20090104T3 HR 20090104 T HR20090104 T HR 20090104T HR P20090104 T HRP20090104 T HR P20090104T HR P20090104 T3 HRP20090104 T3 HR P20090104T3
- Authority
- HR
- Croatia
- Prior art keywords
- solid pharmaceutical
- hydrochloride
- donepesil
- product containing
- pharmaceutical product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Glanulating (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004051055 | 2004-10-19 | ||
| PCT/EP2005/011249 WO2006045512A1 (en) | 2004-10-19 | 2005-10-19 | Solid pharmaceutical composition comprising donepezil hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090104T3 true HRP20090104T3 (hr) | 2009-03-31 |
Family
ID=35464350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090104T HRP20090104T3 (hr) | 2004-10-19 | 2005-10-19 | Kruti farmaceutski pripravak koji sadržava donepezil hidroklorid |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20090130205A9 (sr) |
| EP (3) | EP2039349A1 (sr) |
| JP (1) | JP2008517022A (sr) |
| AT (1) | ATE415148T1 (sr) |
| CA (1) | CA2584547C (sr) |
| CY (1) | CY1109956T1 (sr) |
| DE (1) | DE602005011326D1 (sr) |
| DK (1) | DK1811957T3 (sr) |
| EA (1) | EA012220B1 (sr) |
| ES (1) | ES2317313T3 (sr) |
| HR (1) | HRP20090104T3 (sr) |
| NO (1) | NO20072494L (sr) |
| PL (1) | PL1811957T3 (sr) |
| PT (1) | PT1811957E (sr) |
| RS (1) | RS51271B (sr) |
| SI (1) | SI1811957T1 (sr) |
| UA (1) | UA83152C2 (sr) |
| WO (1) | WO2006045512A1 (sr) |
| ZA (1) | ZA200704023B (sr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515803D0 (en) * | 2005-07-30 | 2005-09-07 | Pliva Hrvatska D O O | Intermediate compounds |
| DE102005060377A1 (de) * | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
| CA2652300A1 (en) * | 2006-05-15 | 2007-11-22 | Acadia Pharmaceuticals Inc. | Pharmaceutical formulations of pimavanserin |
| GB0614586D0 (en) * | 2006-07-22 | 2006-08-30 | Pliva Istrazivacki Inst D O O | Pharmaceutical Formulation |
| EP2117611B1 (en) * | 2007-01-24 | 2014-07-30 | Cook Medical Technologies LLC | Biofilm-inhibiting medical products |
| GR20070100405A (el) * | 2007-06-26 | 2009-01-20 | Genepharm �.�. | Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων |
| DE102007037932A1 (de) * | 2007-08-11 | 2009-02-12 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Donepezilhydrochlorid in amorpher Form enthaltende Tablette |
| DE102009041839A1 (de) * | 2009-09-18 | 2011-03-24 | Dolorgiet Gmbh & Co. Kg | Donepezil-haltige Tabletten |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
| DE102010010998A1 (de) * | 2010-03-10 | 2011-09-15 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I |
| WO2012016708A1 (en) | 2010-08-06 | 2012-02-09 | Ratiopharm Gmbh | Oral dosage form comprising dimebolin and donepezil |
| ES2655492T3 (es) * | 2010-11-30 | 2018-02-20 | Wista Laboratories Ltd. | Formulaciones que comprenden cloruro de metiltioninio |
| EP2502620A1 (en) | 2011-03-24 | 2012-09-26 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising donepezil |
| CA2938671A1 (en) | 2014-02-04 | 2015-08-13 | Forest Laboratories Holdings Limited | Donepezil compositions and method of treating alzheimer's disease |
| CN114272219B (zh) * | 2021-12-30 | 2023-11-10 | 江苏豪森药业集团有限公司 | 一种盐酸多奈哌齐片及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813064D0 (en) * | 1988-06-02 | 1988-07-06 | Euro Celtique Sa | Controlled release dosage forms having defined water content |
| US4956182A (en) * | 1989-03-16 | 1990-09-11 | Bristol-Myers Company | Direct compression cholestyramine tablet and solvent-free coating therefor |
| US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| JPH1053576A (ja) * | 1996-06-07 | 1998-02-24 | Eisai Co Ltd | 塩酸ドネペジルの多形結晶およびその製造法 |
| TW513409B (en) * | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
| WO1997046526A1 (en) * | 1996-06-07 | 1997-12-11 | Eisai Co., Ltd. | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
| AU731282B2 (en) | 1996-06-07 | 2001-03-29 | Eisai Co. Ltd. | Polymorphs of donepezil hydrochloride and process for production |
| EP1017823B1 (en) * | 1997-02-07 | 2004-07-14 | Princeton University | Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
| CN1195862C (zh) * | 1998-02-19 | 2005-04-06 | 札幌啤酒株式会社 | 分离和纯化的包括在蛇麻腺中特异性表达的基因的核酸 |
| US6372760B1 (en) * | 1999-03-31 | 2002-04-16 | Eisai Co., Ltd. | Stabilized composition comprising antidementia medicament |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| PT1260215E (pt) * | 2000-03-01 | 2009-09-03 | Eisai R&D Man Co Ltd | Comprimido de desintegração rápida que contém poli(álcool vinílico) |
| US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
| IN192180B (sr) * | 2001-09-28 | 2004-03-06 | Ranbaxy Lab | |
| TWI231760B (en) * | 2001-12-20 | 2005-05-01 | Chugai Pharmaceutical Co Ltd | Coated lozenge and manufacturing method thereof |
| SI21223A (sl) * | 2002-06-19 | 2003-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom |
| IL150509A (en) | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
| WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| US20040265375A1 (en) | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
| US7560560B2 (en) * | 2003-04-16 | 2009-07-14 | Hetero Drugs Limited | Crystalline forms of donepezil hydrochloride |
| US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
-
2005
- 2005-10-19 EP EP08020395A patent/EP2039349A1/en not_active Withdrawn
- 2005-10-19 EP EP10176222A patent/EP2283811A1/en not_active Withdrawn
- 2005-10-19 EP EP05795965A patent/EP1811957B1/en not_active Revoked
- 2005-10-19 PT PT05795965T patent/PT1811957E/pt unknown
- 2005-10-19 UA UAA200704303A patent/UA83152C2/ru unknown
- 2005-10-19 PL PL05795965T patent/PL1811957T3/pl unknown
- 2005-10-19 RS RSP-2009/0048A patent/RS51271B/sr unknown
- 2005-10-19 DE DE602005011326T patent/DE602005011326D1/de not_active Expired - Lifetime
- 2005-10-19 ES ES05795965T patent/ES2317313T3/es not_active Expired - Lifetime
- 2005-10-19 HR HR20090104T patent/HRP20090104T3/xx unknown
- 2005-10-19 WO PCT/EP2005/011249 patent/WO2006045512A1/en not_active Ceased
- 2005-10-19 CA CA2584547A patent/CA2584547C/en not_active Expired - Fee Related
- 2005-10-19 AT AT05795965T patent/ATE415148T1/de active
- 2005-10-19 DK DK05795965T patent/DK1811957T3/da active
- 2005-10-19 US US11/577,414 patent/US20090130205A9/en not_active Abandoned
- 2005-10-19 EA EA200700673A patent/EA012220B1/ru not_active IP Right Cessation
- 2005-10-19 JP JP2007537202A patent/JP2008517022A/ja active Pending
- 2005-10-19 SI SI200530575T patent/SI1811957T1/sl unknown
-
2007
- 2007-05-15 NO NO20072494A patent/NO20072494L/no not_active Application Discontinuation
- 2007-05-18 ZA ZA2007/04023A patent/ZA200704023B/en unknown
-
2009
- 2009-02-18 CY CY20091100181T patent/CY1109956T1/el unknown
-
2010
- 2010-01-20 US US12/690,498 patent/US20100317694A1/en not_active Abandoned
-
2012
- 2012-01-10 US US13/346,931 patent/US20120283291A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006045512A1 (en) | 2006-05-04 |
| EP2039349A1 (en) | 2009-03-25 |
| ATE415148T1 (de) | 2008-12-15 |
| ES2317313T3 (es) | 2009-04-16 |
| US20100317694A1 (en) | 2010-12-16 |
| EP1811957B1 (en) | 2008-11-26 |
| US20080063705A1 (en) | 2008-03-13 |
| DE602005011326D1 (de) | 2009-01-08 |
| SI1811957T1 (sl) | 2009-04-30 |
| EA012220B1 (ru) | 2009-08-28 |
| EP1811957A1 (en) | 2007-08-01 |
| PL1811957T3 (pl) | 2009-05-29 |
| ZA200704023B (en) | 2008-04-30 |
| EA200700673A1 (ru) | 2007-10-26 |
| PT1811957E (pt) | 2009-01-27 |
| CY1109956T1 (el) | 2014-09-10 |
| EP2283811A1 (en) | 2011-02-16 |
| DK1811957T3 (da) | 2009-03-30 |
| NO20072494L (no) | 2007-07-02 |
| US20120283291A1 (en) | 2012-11-08 |
| RS51271B (sr) | 2010-12-31 |
| CA2584547A1 (en) | 2006-05-04 |
| US20090130205A9 (en) | 2009-05-21 |
| JP2008517022A (ja) | 2008-05-22 |
| CA2584547C (en) | 2014-07-08 |
| UA83152C2 (ru) | 2008-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
| ATE397936T1 (de) | Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| NO20091395L (no) | Nye tiofenderivater | |
| EP2261236A3 (en) | Composition for proteasome inhibition | |
| TW200626558A (en) | Indazolone derivatives | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| EA200700673A1 (ru) | Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид | |
| NO20032371L (no) | Makrolidsolvater | |
| BR0307518A (pt) | Composição farmacêutica | |
| DK1768748T3 (da) | Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf | |
| MEP10209A (en) | Stable emulsion composition | |
| DK1965809T3 (da) | Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner | |
| MY142129A (en) | Amorphous lercanidipine hydrochloride | |
| BRPI0408446A (pt) | tablete de limpeza | |
| TW200510372A (en) | Novel amides useful for treating pain | |
| FR2911278B1 (fr) | Procede d'obtention d'un actif cosmetique depigmentant, principe actif obtenu et compositions l'incluant | |
| TW200518778A (en) | Shampoo composition | |
| DE60306810D1 (de) | Polyethylen-giesszusammensetzung zum herstellen von grossbehältern | |
| EA201200727A1 (ru) | Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения | |
| DE602004022420D1 (de) | Pharmazeutische zusammensetzungen, die cyclische somatostatinanaloga enthalten | |
| NO20051261L (no) | Morfin-6-glukuronidsalt | |
| MXPA06002778A (es) | Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina. | |
| HRP20090547T1 (hr) | Farmaceutski pripravci koji sadrže zd6474 | |
| ATE517109T1 (de) | Isopropanol-wasser-solvat von olanzapin |